Model
Edge
Arca Biopharma Inc.
ABIO
Filing Type
8-K
Filing Date
12/10/2025
Updated
12/11/25, 2:10 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Changes in Board, Management or Compensation
EX-10.1
OFFER LETTER, DATED DECEMBER 1, 2025, BETWEEN ORUKA THERAPEUTICS, INC. AND CHRIS MARTIN
GRAPHIC
Graphic